ANLN and neoplasm: As indicated in the GSE31684 dataset, published by Memorial Sloan-Kettering Cancer Center with 93 patients with high-risk BLCA, the ANLN expression level, on average, significantly increased as tumor stage progress (ANOVA test, P = 0.006, Fig. 2c).